ARMISTICE CAPITAL, LLC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Moleculin Biotech, Inc. (MBRX)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: Moleculin Biotech, Inc. Common Stock, par value $.001 per share
Symbol: MBRX
Shares outstanding: 3.4M shares
Disclosed Ownership: 340K shares
Ownership: 9.99%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 05:51 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	9.99%	340K	0	340K	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	9.99%	340K	0	340K	/s/ Steven Boyd	Steven Boyd